Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00877_DB04855_nanopub.RAlLNwSriQe-Rlnoq6OjBvyPPMkTnV4s6pvyBR4Xycs44#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00877_DB04855 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00877_DB04855 label "DDI between Sirolimus and Dronedarone - Sirolimus is a CYP3A substrate with a narrow therapeutic index thus concomitant therapy with dronedarone will increase plasma levels of sirolimus. Monitor plasma concentrations and adjust dose accordingly. [drugbank_resource:DB00877_DB04855]" assertion.
- drugbank_resource:DB00877_DB04855 identifier "drugbank_resource:DB00877_DB04855" assertion.
- drugbank_resource:DB00877_DB04855 title "DDI between Sirolimus and Dronedarone - Sirolimus is a CYP3A substrate with a narrow therapeutic index thus concomitant therapy with dronedarone will increase plasma levels of sirolimus. Monitor plasma concentrations and adjust dose accordingly." assertion.
- drugbank:DB00877 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00877_DB04855 assertion.
- drugbank:DB04855 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00877_DB04855 assertion.